S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
One Stock Is All You Need  (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
One Stock Is All You Need  (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Closing prices for crude oil, gold and other commodities
Big climate bill; Spending green bucks to boost green energy
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
One Stock Is All You Need  (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
One Stock Is All You Need  (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Closing prices for crude oil, gold and other commodities
Big climate bill; Spending green bucks to boost green energy
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
One Stock Is All You Need  (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
One Stock Is All You Need  (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Closing prices for crude oil, gold and other commodities
Big climate bill; Spending green bucks to boost green energy
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
S&P 500   4,207.27
DOW   33,336.67
QQQ   324.08
Find and Profitably Trade Stocks at 52-Week Lows
One Stock Is All You Need  (Ad)pixel
Why Invest in High-Yield Dividend Stocks?
3 Stable Growth Stocks for Bumpy Times
Disney (NYSE: DIS) Shares Just Gave Investors A Massive Signal
One Stock Is All You Need  (Ad)pixel
Solar Stocks Shine Brightly After Passage Of Clean Energy Bill
Closing prices for crude oil, gold and other commodities
Big climate bill; Spending green bucks to boost green energy
Our #1 Small-Cap Stock for [MONTH] (Ad)pixel
NASDAQ:OFIX

Orthofix Medical - OFIX Stock Forecast, Price & News

$23.03
+0.51 (+2.26%)
(As of 08/11/2022 12:00 AM ET)
Add
Compare
Today's Range
$22.63
$23.09
50-Day Range
$21.98
$27.47
52-Week Range
$21.66
$43.30
Volume
59,860 shs
Average Volume
99,251 shs
Market Capitalization
$458.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$45.00

Orthofix Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
95.4% Upside
$45.00 Price Target
Short Interest
Bearish
2.22% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.52mentions of Orthofix Medical in the last 14 days
Based on 10 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.22%
From $0.45 to $0.46 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.93 out of 5 stars

Medical Sector

813th out of 1,112 stocks

Surgical & Medical Instruments Industry

79th out of 113 stocks

OFIX stock logo

About Orthofix Medical (NASDAQ:OFIX) Stock

Orthofix Medical Inc. operates as a medical device and biologics company in the United States, Italy, Germany, France, the United Kingdom, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion, as well as used as a therapeutic treatment for non-spinal and appendicular fractures. This segment also designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and a portfolio of products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions, as well as markets regenerative non-tissue biologic solutions derived from synthetic materials. The Global Orthopedics segment designs, develops, and markets orthopedic products that are used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

Wall Street Analyst Weigh In

Separately, StockNews.com raised Orthofix Medical from a "hold" rating to a "buy" rating in a research report on Monday.

Orthofix Medical Price Performance

Shares of NASDAQ:OFIX opened at $22.52 on Thursday. The business has a fifty day moving average of $24.83 and a two-hundred day moving average of $28.98. Orthofix Medical has a 52-week low of $21.66 and a 52-week high of $43.30. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.15 and a quick ratio of 1.95.

Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Stock News Headlines

Orthofix Reports Second Quarter 2022 Results
Foot And Ankle Devices Global Market Report 2022
Orthofix Reports First Quarter 2022 Results
See More Headlines
Receive OFIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orthofix Medical and its competitors with MarketBeat's FREE daily newsletter.

OFIX Company Calendar

Last Earnings
11/05/2021
Today
8/12/2022
Next Earnings (Estimated)
11/04/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NASDAQ:OFIX
CUSIP
N6748L10
Employees
1,087
Year Founded
1980

Price Target and Rating

Average Stock Price Forecast
$45.00
High Stock Price Forecast
$45.00
Low Stock Price Forecast
$45.00
Forecasted Upside/Downside
+95.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-38,380,000.00
Pretax Margin
-2.92%

Debt

Sales & Book Value

Annual Sales
$464.48 million
Cash Flow
$3.28 per share
Book Value
$17.17 per share

Miscellaneous

Free Float
19,215,000
Market Cap
$458.57 million
Optionable
Optionable
Beta
1.01

Social Links


Key Executives














OFIX Stock - Frequently Asked Questions

Should I buy or sell Orthofix Medical stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" OFIX shares.
View OFIX analyst ratings
or view top-rated stocks.

What is Orthofix Medical's stock price forecast for 2022?

1 Wall Street analysts have issued 12 month target prices for Orthofix Medical's stock. Their OFIX share price forecasts range from $45.00 to $45.00. On average, they anticipate the company's share price to reach $45.00 in the next year. This suggests a possible upside of 95.4% from the stock's current price.
View analysts price targets for OFIX
or view top-rated stocks among Wall Street analysts.

How have OFIX shares performed in 2022?

Orthofix Medical's stock was trading at $31.09 at the beginning of the year. Since then, OFIX shares have decreased by 25.9% and is now trading at $23.03.
View the best growth stocks for 2022 here
.

When is Orthofix Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 4th 2022.
View our OFIX earnings forecast
.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc. (NASDAQ:OFIX) released its earnings results on Friday, November, 5th. The medical device company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.03. The medical device company earned $112.43 million during the quarter, compared to the consensus estimate of $112.90 million. Orthofix Medical had a positive trailing twelve-month return on equity of 1.90% and a negative net margin of 8.00%. During the same quarter last year, the business posted $0.31 earnings per share.

What guidance has Orthofix Medical issued on next quarter's earnings?

Orthofix Medical issued an update on its FY 2022 earnings guidance on Friday, August, 12th. The company provided EPS guidance of $0.45-$0.55 for the period. The company issued revenue guidance of $455.00 million-$465.00 million, compared to the consensus revenue estimate of $479.18 million.

What is Brad Mason's approval rating as Orthofix Medical's CEO?

32 employees have rated Orthofix Medical Chief Executive Officer Brad Mason on Glassdoor.com. Brad Mason has an approval rating of 73% among the company's employees.

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Edwards Lifesciences (EW), Gilead Sciences (GILD), Biogen (BIIB), Pfizer (PFE), Exxon Mobil (XOM), Advanced Micro Devices (AMD), bluebird bio (BLUE) and Esperion Therapeutics (ESPR).

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Paradice Investment Management LLC (4.80%), Victory Capital Management Inc. (1.26%), JPMorgan Chase & Co. (0.86%), Royce & Associates LP (0.80%), Paradigm Capital Management Inc. NY (0.75%) and Principal Financial Group Inc. (0.67%). Insiders that own company stock include Brad Mason, Catherine M Burzik, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Michael E Paolucci, Rice Doug and Ronald A Matricaria.
View institutional ownership trends
.

How do I buy shares of Orthofix Medical?

Shares of OFIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $23.03.

How much money does Orthofix Medical make?

Orthofix Medical (NASDAQ:OFIX) has a market capitalization of $458.57 million and generates $464.48 million in revenue each year. The medical device company earns $-38,380,000.00 in net income (profit) each year or ($1.86) on an earnings per share basis.

How many employees does Orthofix Medical have?

The company employs 1,087 workers across the globe.

When was Orthofix Medical founded?

Orthofix Medical was founded in 1980.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The official website for the company is www.orthofix.com. The medical device company can be reached via phone at (214) 937-2000, via email at markquick@orthofix.com, or via fax at 599 9 461 6978.

This page (NASDAQ:OFIX) was last updated on 8/12/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.